Monday, October 5, 2015   

GSK to sell oncology arm to Novartis
(04-22 14:22)

British pharmaceutical giant GlaxoSmithKline is to sell its oncology business to peer Novartis for US$16 billion and to buy the Swiss company's vaccines division, GSK announced on Tuesday.
Under a "major three-part transaction'' GSK and Novartis have agreed also to create a consumer healthcare business, according to a statement issued by GlaxoSmithKline. --AFP
Other Business breaking news:
US stocks tumble on weak jobs report (10-02 21:52)
France's Total gets Iran gas station license (10-02 21:50)
Air France to shed 2,900 jobs (10-02 21:34)
US hirings slow in September (10-02 21:33)
European benchmarks jump (10-02 20:06)
Finance chiefs head to Lima to take stock of economic woes (10-02 18:40)
Hang Seng bounces by 3pc at close (10-02 17:24)
European stocks extend rally (10-02 16:28)
Nikkei closes flat (10-02 14:39)
Hang Seng rallies (10-02 13:25)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.